Skip to main content
Caplight Logo









Twilight Bioscience, Inc.

Twilight Bioscience, Inc.

Private
Beverly, MassachusettsHealthcare & Life Scienceshttps://www.twlbio.com/

Last Round

Grant

Feb 1, 2025

Total Funding Raised

$3.3M

Company Overview

Twilight Bioscience, Inc. is a biotechnology company that develops precision active immunotherapies for chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunotherapyprecision medicinebiotechnologyFc-fusionneurodegenerative diseaseactive immunotherapybiologicsvaccine platformdrug discoverymonoclonal antibodytherapeutic pipelinebiotech startupnext-gen vaccines

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Twilight Bioscience, Inc. Comparables

Compare Twilight Bioscience, Inc. with similar companies based on industry and business-model similarity.

Twilight Bioscience, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vaxxinity, Inc.
78%
Nuravax
76%
AC Immune SA
71%

Twilight Bioscience, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2025
SeedSep 1, 2022

Twilight Bioscience, Inc. Investors

Notable investors and investment history

Twilight Bioscience, Inc. investors
InvestorRounds
Formation Venture EngineeringSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2025

    $300K grant received from the United States Federal Government.

  • Sep 1, 2022

    $3M round with Formation Venture Engineering and Akston Biosciences.

Twilight Bioscience, Inc. Filings

Explore SEC and related filing metadata, where available.

Twilight Bioscience, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Twilight Bioscience, Inc.'s valuation, stock price, and market status.

Is Twilight Bioscience, Inc. a public or private company?

Twilight Bioscience, Inc. is a private company.

What is the current stock price of Twilight Bioscience, Inc.?

Twilight Bioscience, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Twilight Bioscience, Inc. worth (valuation)?

Valuation information for Twilight Bioscience, Inc. is not publicly available.

Can I buy Twilight Bioscience, Inc. stock?

Twilight Bioscience, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Twilight Bioscience, Inc.'s last funding round?

Twilight Bioscience, Inc.'s most recent funding round was Grant on February 1, 2025.

Who are the main investors in Twilight Bioscience, Inc.?

Key investors in Twilight Bioscience, Inc. include Formation Venture Engineering.

Will Twilight Bioscience, Inc. IPO soon?

No public IPO plans have been announced for Twilight Bioscience, Inc..

How can I track Twilight Bioscience, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Twilight Bioscience, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeverly, Massachusetts
Year Founded2022
Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?